Literature DB >> 26205298

Monte Carlo Evaluation of Auger Electron-Emitting Theranostic Radionuclides.

Nadia Falzone1, José M Fernández-Varea2, Glenn Flux3, Katherine A Vallis4.   

Abstract

UNLABELLED: Several radionuclides used in medical imaging emit Auger electrons, which, depending on the targeting strategy, either may be exploited for therapeutic purposes or may contribute to an unintentional mean absorbed dose burden. In this study, the virtues of 12 Auger electron-emitting radionuclides were evaluated in terms of cellular S values in concentric and eccentric cell-nucleus arrangements and by comparing their dose-point kernels.
METHODS: The Monte Carlo code PENELOPE was used to transport the full particulate spectrum of (67)Ga, (80m)Br, (89)Zr, (90)Nb, (99m)Tc, (111)In, (117m)Sn, (119)Sb, (123)I, (125)I, (195m)Pt, and (201)Tl by means of event-by-event simulations. Cellular S values were calculated for varying cell and nucleus radii, and the effects of cell eccentricity on S values were evaluated. Dose-point kernels were determined up to 30 μm. Energy deposition at DNA scales was also compared with an α emitter, (223)Ra.
RESULTS: PENELOPE-determined S values were generally within 10% of MIRD values when the source and target regions strongly overlapped, that is, S(nucleus←nucleus) configurations, but greater differences were noted for S(nucleus←cytoplasm) and S(nucleus←cell surface) configurations. Cell eccentricity had the greatest effect when the nucleus was small, compared with the cell size, and when the radiation sources were on the cell surface. Dose-point kernels taken together with the energy spectra of the radionuclides can account for some of the differences in energy deposition patterns between the radionuclides. The energy deposition of most Auger electron emitters at DNA scales of 2 nm or less exceeded that of a monoenergetic 5.77-MeV α particle, but not for (223)Ra.
CONCLUSION: A single-cell dosimetric approach is required to evaluate the efficacy of individual radionuclides for theranostic purposes, taking cell geometry into account, with internalizing and noninternalizing targeting strategies.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  Auger electron emitters; Monte Carlo simulation; S values; cellular dosimetry; dose point kernels; targeted radiotherapy; theranostics

Mesh:

Substances:

Year:  2015        PMID: 26205298     DOI: 10.2967/jnumed.114.153502

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  18 in total

1.  A model for optimizing delivery of targeted radionuclide therapies into resection cavity margins for the treatment of primary brain cancers.

Authors:  Raghu Raghavan; Roger W Howell; Michael R Zalutsky
Journal:  Biomed Phys Eng Express       Date:  2017-05-05

2.  Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018.

Authors:  Nadia Falzone; Rebecca Gregory; Matthew Aldridge; Samantha Ya Terry; Glenn Flux
Journal:  Br J Radiol       Date:  2019-05-20       Impact factor: 3.039

3.  Monte Carlo single-cell dosimetry using Geant4-DNA: the effects of cell nucleus displacement and rotation on cellular S values.

Authors:  Ramak Salim; Payvand Taherparvar
Journal:  Radiat Environ Biophys       Date:  2019-03-29       Impact factor: 1.925

4.  Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.

Authors:  Dongyoul Lee; Mengshi Li; Bryan Bednarz; Michael K Schultz
Journal:  Radiat Res       Date:  2018-06-26       Impact factor: 2.841

5.  In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201.

Authors:  Vincenzo Abbate; Samantha Y A Terry; Katarzyna M Osytek; Philip J Blower; Ines M Costa; Gareth E Smith
Journal:  EJNMMI Res       Date:  2021-07-05       Impact factor: 3.138

Review 6.  Auger: The future of precision medicine.

Authors:  Giacomo Pirovano; Thomas C Wilson; Thomas Reiner
Journal:  Nucl Med Biol       Date:  2021-03-19       Impact factor: 2.408

7.  Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119

Authors:  Parmissa Randhawa; Aeli P Olson; Shaohuang Chen; Kaley Lexi Gower-Fry; Cornelia Hoehr; Jonathan W Engle; Caterina F Ramogida; Valery Radchenko
Journal:  Curr Radiopharm       Date:  2021

8.  A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XXSb(III) Complex, and Selective Chelation of Radioantimony (119Sb) from Its Sn Target.

Authors:  Aeli P Olson; Li Ma; Yutian Feng; Firouzeh Najafi Khosroshahi; Steven P Kelley; Eduardo Aluicio-Sarduy; Todd E Barnhart; Heather M Hennkens; Paul A Ellison; Silvia S Jurisson; Jonathan W Engle
Journal:  Inorg Chem       Date:  2021-10-04       Impact factor: 5.165

9.  Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy.

Authors:  Elise Verger; Jordan Cheng; Vittorio de Santis; Madeleine Iafrate; Jessica A Jackson; Cinzia Imberti; Gilbert O Fruhwirth; Philip J Blower; Michelle T Ma; Daniel R Burnham; Samantha Y A Terry
Journal:  Nucl Med Biol       Date:  2021-06-15       Impact factor: 2.408

10.  Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy.

Authors:  Edward O'Neill; Veerle Kersemans; P Danny Allen; Samantha Y A Terry; Julia Baguña Torres; Michael Mosley; Sean Smart; Boon Quan Lee; Nadia Falzone; Katherine A Vallis; Mark W Konijnenberg; Marion de Jong; Julie Nonnekens; Bart Cornelissen
Journal:  J Nucl Med       Date:  2019-11-22       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.